Irisin in atherosclerosis

Zhe-Bin Cheng,Liang Huang,Xuan Xiao,Jia-Xiang Sun,Zi-Kai Zou,Jie-Feng Jiang,Cong Lu,Hai-Ya Zhang,Chi Zhang
DOI: https://doi.org/10.1016/j.cca.2021.08.022
IF: 6.314
2021-11-01
Clinica Chimica Acta
Abstract:Irisin, a novel exercise-induced myokine, has been shown to play important roles in increasing white adipose tissue browning, regulating energy metabolism and improving insulin resistance. Growing evidence suggests a direct role for irisin in preventing atherosclerosis (AS) by inhibiting oxidative stress, improving dyslipidemia, facilitating anti-inflammation, reducing cellular damage and recovering endothelial function. In addition, some studies have noted that serum irisin levels play an essential role in cardiovascular diseases (CVDs) risk prediction, highlighting that irisin has the potential to be a useful predictive marker and therapeutic target of AS, especially in monitoring therapeutic efficacy. This review summarizes the understanding of irisin-mediated regulation in essential biological pathways and functions in atherosclerosis and prompts further exploitation of the biological properties of irisin in the pathogenesis of atherosclerosis.
medical laboratory technology
What problem does this paper attempt to address?